A Randomized, Double-Blind, Controlled Trial of Hydromorphone (Immediate and Sustained- Release) vs Morphine (Immediate and Sustained-release) in Cancer Pain.
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2009
At a glance
- Drugs Hydromorphone; Morphine
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors ALZA Corporation
- 14 Jul 2009 Actual patient number (202) added as reported by ClinicalTrials.gov.
- 02 Jan 2007 New trial record.